Additionally, a mechanistic study revealed that H19 accelerated cell proliferation and metastasis by modulating Wnt5a/β-catenin signaling via miR-342, providing novel therapeutic targets in glioma (Fig. 5G) 154. Here, H19 is linked to glioma.